As the new year begins, medical device leaders face evolving macro and sector-specific trends. These will amplify longstanding challenges and spawn new barriers to profitable growth. Forward-looking firms are revisiting their Revenue Lifecycle Management (RLM) approach to ensure they will operate on firm footing during 2024 and accelerate toward profitable growth.